Glycogen storage disease due to acid maltase deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Glycogen storage disease due to acid maltase deficiency

Synonyms: Alpha-1,4-glucosidase acid deficiency | GSD due to acid maltase deficiency | GSD type 2 | GSD type II | Glycogen storage disease type 2 | Glycogen storage disease type II | Glycogenosis due to acid maltase deficiency | Glycogenosis type 2 | Glycogenosis type II | Pompe disease

A rare lysosomal storage disease characterized by lysosomal accumulation of glycogen particularly in skeletal cardiac and respiratory muscles as well as the liver and nervous system due to acid maltase deficiency. The clinical spectrum comprises infantile-onset disease with severe hypertrophic cardiomyopathy generalized muscle weakness poor feeding and failure to thrive and respiratory insufficiency and late-onset disease manifesting before or after twelve months of age without cardiomyopathy with proximal muscle weakness and respiratory insufficiency.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Glycogen storage disease due to acid maltase deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Canadian Society for Mucopolysaccharide & Related Diseases Inc.

The Canadian Society for Mucopolysaccharide and Related Diseases Inc. (The Canadian MPS Society), founded in 1984, serves all Canadians affected by MPS and related diseases through support, education, advocacy and by advancing research.

Emory Lysosomal Storage Disease Center

The Emory Lysosomal and Peroxisomal Storage Disease Center is devoted to remaining on the cutting edge of research and treatment providing comprehensive and compassionate care for all of our patients affected by lysosomal storage diseases.

Grant’s Giants Pompe Awareness Nonprofit

To serve, educate, advocate, and support the Pompe community both locally and nationally. Grant's Giants will offer scholarships to pediatric Pompe families to attend the Pediatric Pompe Conference at Duke and be seen by the Pompe clinical and research team at Duke, fund durable medical equipment for Pompe patients, host an annual Pompe Family Meet Up, and advocate for newborn screening.

Lysosomal Storage Disorders Support Society

LSDSS endeavors to transform the life of children affected by rare Lysosomal Storage Disorders. Our mission is to increase awareness about the prevention of such disorders in future offspring as well as counsel the affected patients and families on how to cope with existing conditions, ensuring no patient or family living with an LSD ever feels alone.

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

My Faulty Gene

My Faulty Gene is a nonprofit organization which provides information and assistance to any individual whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. We believe that everyone in need of genetic testing should have access to it.

association for glycogen storage disease

The Association for Glycogen Storage Disease (AGSD) is a patient advocacy organization dedicated to protecting and promoting the best interest of all persons affected by the glycogen storage disease. • AGSD is committed to the identification, treatment, and cure of glycogen storage disease through programs of education, advocacy, research, and patient services.

Clinical Trials

For a list of clinical trials in this disease area, please click here.